Home
RA Capital Nexus Fund III, Director: Climb Bio CLYM Buy · Filed 25/12/15
Trade details
- Type
- Insider buy
- Amount
- $464,555.82
- Shares · price
- 213,099 sh · $2.18 a share
- Held after
- 3,294,856 sh
- Stock
- Climb Bio CLYM
- Trade date
- 25/12/11
- Filed
- 25/12/15
- Days to filing
- 4 days
First buy in 1 years
- Since the last buy
- 1.5 years
- Last buy
- 24/06/27
- Insiders buying this week
- 7 insiders
- Holding change
- +6.9%
Climb Bio trades, last 26 weeks
What else happened in Climb Bio around then
Filed or reported within 30 days of the trade day · 25/11/11~01/10RA Capital Nexus Fund III's recent trades
- RA Capital Nexus Fund III
Planned saleSepterna
Planned saleSepterna
SEPN
$36M
746,500 sh
$36M
Filed 08/12
Traded 08/12
- RA Capital Nexus Fund III
BuyArtiva Biotherapeutics
BuyArtiva Biotherapeutics
ARTV
$275.3K
31,000 sh
$275.3K
Filed 06/29
Traded 06/25
- RA Capital Nexus Fund III
BuyArtiva Biotherapeutics
BuyArtiva Biotherapeutics
ARTV
$16.8K
1,876 sh
$16.8K
Filed 06/29
Traded 06/26
- RA Capital Nexus Fund III
BuyArtiva Biotherapeutics
BuyArtiva Biotherapeutics
ARTV
$3.4M
391,019 sh
$3.4M
Filed 06/16
Traded 06/12
- RA Capital Nexus Fund III
BuyArtiva Biotherapeutics
BuyArtiva Biotherapeutics
ARTV
$1.1M
124,893 sh
$1.1M
Filed 06/16
Traded 06/16
